(Q34047372)

English

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

0 references

1 reference

Europe PubMed Central

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C Mascaux

1

1 reference

Europe PubMed Central

30 July 2017

M Paesmans

2

1 reference

Europe PubMed Central

30 July 2017

T Berghmans

3

1 reference

Europe PubMed Central

30 July 2017

F Branle

4

1 reference

Europe PubMed Central

30 July 2017

J J Lafitte

5

1 reference

Europe PubMed Central

30 July 2017

F Lemaitre

6

1 reference

Europe PubMed Central

30 July 2017

A P Meert

7

1 reference

Europe PubMed Central

30 July 2017

P Vermylen

8

1 reference

Europe PubMed Central

30 July 2017

J P Sculier

9

1 reference

Europe PubMed Central

30 July 2017

European Lung Cancer Working Party (ELCWP)

10

1 reference

Europe PubMed Central

30 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2000

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

30

1 reference

Europe PubMed Central

30 July 2017

23-36

1 reference

Europe PubMed Central

30 July 2017

1

1 reference

Europe PubMed Central

30 July 2017

Small cell lung cancer. State-of-the-art therapy 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance chemotherapy for small cell lung cancer: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy in small cell lung carcinoma: A randomized study of two intensive regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of long-term survival in extensive small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Vincristine, doxorubicin and cyclophosphamide with and without etoposide in limited small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide versus methotrexate in small cell bronchial carcinoma. A randomized study of two types of four-drug chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing cyclophosphamide, doxorubicin, vincristine (CAV) with cyclophosphamide, etoposide, vincristine, methotrexate (CEVM) in patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomised study in limited disease small cell carcinoma--doxorubicin and vincristine plus either cyclophosphamide or etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Does the substitution of cisplatin in a standard four drug regimen improve survival in small cell carcinoma of the lung? A comparison of two chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900127-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(00)00127-6

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34047372&oldid=1993785208"